Community Engagement Alliance Against Disparities

NCT06607341 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 664

Last updated 2026-05-11

No results posted yet for this study

Summary

The Community Engagement Alliance against Disparities - Washington District of Columbia, Maryland, Virginia (CEAL DMV), is a multi-community and multi-university consortium. Through collaboration and shared leadership, the CEAL-DMV the consortium- comprising five institutions: George Washington University, Howard University, Johns Hopkins University, Morgan State University, and the University of Maryland, Baltimore-has established a regional structure for bi-directional community involvement to engender trust and foster communication. Each site builds on thriving community partnerships, which have been instrumental in enhancing trust, community capacity, and readiness to reduce health disparities.

Conditions

Interventions

BEHAVIORAL

Multi-level, community-digital health promotion intervention

Community level activities: 1. Capacity building for community-based organizations, and 2. Community health workers will facilitate linkage to community resources, including health/social service access referrals and client social support. Individual level activities: 1. Goal setting and self-monitoring, 2. Tailored feedback, 3. Personalized lifestyle coaching, health and social service referral support, and 4. Digital access and digital health literacy skills building Social network: 1. Social network-based activities, and 2. Digital health literacy skills building

Sponsors & Collaborators

  • Baltimore CONNECT

    collaborator UNKNOWN
  • Coaching Salud Holistica

    collaborator UNKNOWN
  • La Clinica del Pueblo

    collaborator UNKNOWN
  • Rivera Group

    collaborator UNKNOWN
  • The Medi Inc.

    collaborator UNKNOWN
  • Westat

    collaborator OTHER
  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Cheryl Himmelfarb, PhD, MSN, BS · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-20
Primary Completion
2026-12-20
Completion
2027-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06607341 on ClinicalTrials.gov